IJGC conversations

In this IJGC podcast, Dr. Pedro Ramirez discusses SENTIX Trial with David Cibula.

Dr. David Cibula graduated from the First Faculty of Medicine at Charles University in Prague in 1992. Since 2003, he has served as the Chair of the Gynecological Oncology Center at the University Hospital in Prague, and in 2022, he became the head of the Department of Gynecology, Obstetrics, and Neonatology.

He is a former President of the European S...

In this IJGC podcast, Dr. Pedro Ramirez discusses RAMP 201 Results: Avutometinib and Defactinib in Low-Grade Serous Ovarian Cancer with Susana N Banerjee and Rachel N. Grisham.

Prof Susana Banerjee MBBS MA PhD FRCP is a Consultant Medical Oncologist and Research Lead for the Gynaecology Unit at The Royal Marsden NHS Foundation Trust, London. She is also Professor in Women’s Cancers at the Institute of Cancer Research. Dr Banerjee s...

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Drs. Tyler Hillman and Allison Lynn Brodsky to discuss Surgical Approach in Recurrent Granulosa Cell Tumor.

Tyler Hillman, MD, PhD, is a board-certified gynecologic oncologist at UC San Diego Health, where he specializes in medical and surgical management of gynecologic cancers, with expertise in minimally invasive surgery, symptom management, an...

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Bradley Monk to discuss ctDNA: Results from CALLA Trial.

Bradley Monk, MD, FACOG, FACS is a board-certified gynecologic oncologist with Florida Cancer Specialists & Research Institute and medical director of the Late-Stage Clinical Research Program. He provides care to patients at the FCS West Palm Beach location. Dr. Monk has extensive l...

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Frédéric Amant to discuss ESGO/INCIP 2025 Guidelines for Cancer in Pregnancy.

Frédéric Amant (MD, PhD) received his medical degree from the University of Leuven (KU Leuven), Belgium in 1992, completed his specialty training as an obstetrician/gynecologist in 1998 and his subspecialty training in gynecologic oncology in 2000. He defended his t...

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Anna Fagotti to discuss HIPEC in Platinum-Sensitive Ovarian Cancer (HORSE Trial).

Anna Fagotti is a Professor and Consultant of Gynecologic Oncology at A. Gemelli University Hospital Foundation IRCCS. She is the President of ESGO - European Society of Gynaecological Oncology. Her research interests are Obstetrics and Gynecology, Gynecologic Onco...

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Drs. Ilaria Capasso, Camilla Nero, and Evelyn A. Reynolds to discuss ctDNA in Endometrial Cancer .

Dr. Capasso completed her OBGYN residency at Fondazione Policlinico Agostino Gemelli (Rome, Italy), where she worked in the Gynecologic Oncology Unit with a focus on clinical and translational research in endometrial cancer. From May 2022 to May 2023,...

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Marie Plante to discuss minimally invasive surgery in simple hysterectomy from the subanalysis of SHAPE trial.

Dr. Plante has a major interest in minimally invasive surgical (MIS) approaches in the treatment of gynecologic cancers and in fertility-preserving surgery for young women with cervical cancer. She is currently leading two important int...

In this IJGC podcast, Dr. Pedro Ramirez discusses Impact of Surgical Timing and Residual Disease in Ovarian Cancer with Martina Angeles and Alejandra Martinez.

Martina Angeles is a gynecologic oncology specialist at Vall d’Hebron University Hospital in Barcelona. She trained in Obstetrics and Gynecology at Hospital Clínic de Barcelona and completed an ESGO-accredited fellowship in gynecologic oncology (2018–2020). In 2023, she earn...

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Floriane Jochum to discuss Impact of RCTs on Clinical Practice. 

Dr. Floriane Jochum is a Gynecologic Oncologist at Strasbourg University Hospital in France. She completed her PhD in cancer research and computational epidemiology at Institut Curie in Paris. Her doctoral work focused on the multiple applications of real-world data in gynecolog...

In this IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez discusses Lymphadenectomy in Low-Grade Ovarian Cancer with Elizabeth Tubridy and Dimitrios Nasioudis. 

Elizabeth Tubridy is a 3rd year Gynecologic Oncology Fellow at the Hospital of the University of Pennsylvania. She received her Bachelor of Science from Georgetown University and obtained her medical degree from Albert Einstein College of Medicine. She completed her Obstetr...

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Henri Azaïs to discuss ctDNA in Ovarian Cancer. 

Dr. Henri Azaïs is a gynaecological surgeon specialising in the surgical management of gynaecological cancers at the Hôpital Européen Georges Pompidou in Paris - France. His translational research focuses on late-stage ovarian cancer and in particular on the role of circulating tumour DNA in this ...

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Drs. Christianne Lok and Michael Seckl to discuss 2025 GTD Guidelines. 

Christianne Lok is a leading expert in gynecologic oncology, renowned for her work on cancer diagnosis and treatment during pregnancy as part of the International Network on Cancer, Infertility and Pregnancy (INCIP). She plays a pivotal role in research and clinical guidelines ...

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Núria Agustí and David Viveros-Carreño to discuss Radiation alone vs Chemoradiation in Intermediate Risk Cervical Cancer. Dr. Agustí specializes in gynecologic oncology at Hospital Clinic of Barcelona. She is currently a PhD researcher at the University of Barcelona and engaged in a postdoctoral fellowship at MD Anderson Cancer Center, USA. She ...